179 related articles for article (PubMed ID: 9511934)
1. Strategies for correcting the delta F508 CFTR protein-folding defect.
Brown CR; Hong-Brown LQ; Welch WJ
J Bioenerg Biomembr; 1997 Oct; 29(5):491-502. PubMed ID: 9511934
[TBL] [Abstract][Full Text] [Related]
2. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis: a disease of altered protein folding.
Qu BH; Strickland E; Thomas PJ
J Bioenerg Biomembr; 1997 Oct; 29(5):483-90. PubMed ID: 9511933
[TBL] [Abstract][Full Text] [Related]
5. Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.
Zhang XM; Wang XT; Yue H; Leung SW; Thibodeau PH; Thomas PJ; Guggino SE
J Biol Chem; 2003 Dec; 278(51):51232-42. PubMed ID: 14532265
[TBL] [Abstract][Full Text] [Related]
6. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator.
Younger JM; Chen L; Ren HY; Rosser MF; Turnbull EL; Fan CY; Patterson C; Cyr DM
Cell; 2006 Aug; 126(3):571-82. PubMed ID: 16901789
[TBL] [Abstract][Full Text] [Related]
7. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
[TBL] [Abstract][Full Text] [Related]
8. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
9. Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.
Bagdany M; Veit G; Fukuda R; Avramescu RG; Okiyoneda T; Baaklini I; Singh J; Sovak G; Xu H; Apaja PM; Sattin S; Beitel LK; Roldan A; Colombo G; Balch W; Young JC; Lukacs GL
Nat Commun; 2017 Aug; 8(1):398. PubMed ID: 28855508
[TBL] [Abstract][Full Text] [Related]
10. CFTR: folding, misfolding and correcting the ΔF508 conformational defect.
Lukacs GL; Verkman AS
Trends Mol Med; 2012 Feb; 18(2):81-91. PubMed ID: 22138491
[TBL] [Abstract][Full Text] [Related]
11. Targeting CFTR: how to treat cystic fibrosis by CFTR-repairing therapies.
Amaral MD
Curr Drug Targets; 2011 May; 12(5):683-93. PubMed ID: 21039334
[TBL] [Abstract][Full Text] [Related]
12. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the localization of STE6/CFTR chimeras in a Saccharomyces cerevisiae model for the cystic fibrosis defect CFTR delta F508.
Paddon C; Loayza D; Vangelista L; Solari R; Michaelis S
Mol Microbiol; 1996 Mar; 19(5):1007-17. PubMed ID: 8830258
[TBL] [Abstract][Full Text] [Related]
14. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
[TBL] [Abstract][Full Text] [Related]
15. Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments.
Sharma M; Benharouga M; Hu W; Lukacs GL
J Biol Chem; 2001 Mar; 276(12):8942-50. PubMed ID: 11124952
[TBL] [Abstract][Full Text] [Related]
16. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.
Sato S; Ward CL; Krouse ME; Wine JJ; Kopito RR
J Biol Chem; 1996 Jan; 271(2):635-8. PubMed ID: 8557666
[TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.
Rubenstein RC; Egan ME; Zeitlin PL
J Clin Invest; 1997 Nov; 100(10):2457-65. PubMed ID: 9366560
[TBL] [Abstract][Full Text] [Related]
18. Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR.
Zhang F; Kartner N; Lukacs GL
Nat Struct Biol; 1998 Mar; 5(3):180-3. PubMed ID: 9501909
[TBL] [Abstract][Full Text] [Related]
19. Mutant (delta F508) cystic fibrosis transmembrane conductance regulator Cl- channel is functional when retained in endoplasmic reticulum of mammalian cells.
Pasyk EA; Foskett JK
J Biol Chem; 1995 May; 270(21):12347-50. PubMed ID: 7539001
[TBL] [Abstract][Full Text] [Related]
20. Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing.
Teem JL; Carson MR; Welsh MJ
Recept Channels; 1996; 4(1):63-72. PubMed ID: 8723647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
